Pulmonary Cancer
28
6
7
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.7%
3 terminated out of 28 trials
81.3%
-5.3% vs benchmark
7%
2 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (28)
Enhanced COPD Management in Suspected Lung Cancer Patients
Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Erector Spinae Block for Thoracic Surgery
Precision Lung Cancer Survivorship Care Intervention
B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Tunisian Lung Cancer Study
Cios Mobile 3D Spin for Robotic Bronchoscopy
The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
Main Postoperative Complications After COVID-19
Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections
A Phase I Study of iPS Cell Generation From Patients With COPD
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Study of Arsenic Trioxide in Small Cell Lung Cancer
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors